2024 annual financial data
Chemomab Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -14,739,000 USD and net income was -13,945,000 USD.
Operating cash flow was -15,459,024 USD.
Get free Chemomab Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,739,000 USD
- Net income
- -13,945,000 USD
- Operating cash flow
- -15,459,024 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Chemomab Therapeutics financial years